We observed no significant decrease in omentum weight at day 42 post-ID8 tumor challenge in mice treated with CGX1321 and anti-CD8+β antibody, in comparison to mice who did not receive CGX1321 or antibody, p value = 0.318. This evidence concerns the gene CD8A and neoplasm.